Approval · Notice of Compliance 1182 · 2000
OPTIMARK: Notice of Compliance 1182
Issued December 11, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1182
- Date
- December 11, 2000
- Company
- Mallinckrodt MedicalAthlone, WM, Ireland
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Contrast agent for magnetic resonance imaging
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTIMARK | 02242986 | Cancelled Post Market |
Medicinal ingredients
- GADOVERSETAMIDE 330.9 MG per ML